Physician profile
Shailesh Zaveri
NPI 1104898345
$982.45
in general payments reported to CMS, 2019-2025
17 companies · $43.10 in 2025
The $43.10 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $209 · 2020: $89.18 · 2022: $389 · 2023: $98.55 · 2024: $154 · 2025: $43.10.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $295.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $295.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $241.65 | 2019-2024 | |
| E.R. Squibb & Sons, L.L.C. | $233.78 | 2019-2023 | Eliquis |
| Amgen INC. | $61.78 | 2019-2024 | Repatha |
| Astrazeneca Pharmaceuticals LP | $60.35 | 2019-2024 | Farxiga |
| Watermark Medical, INC. | $58.08 | 2022 | |
| Pfizer INC. | $54.27 | 2019-2022 | |
| Abbott Laboratories | $39.67 | 2024 | Cardiomems |
| Novo Nordisk INC | $34.37 | 2019-2020 | |
| Cleerly, INC. | $31.86 | 2025 | Cleerly Ischemia, Cleerly Labs |
| Boston Scientific Corporation | $31.47 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $28.68 | 2019 | |
| Angiodynamics, INC. | $24.03 | 2019 | |
| Infobionic, INC | $21.11 | 2020 | |
| Sanofi-Aventis U.S. LLC | $19.52 | 2019 | |
| Alnylam Pharmaceuticals INC. | $18.04 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $12.55 | 2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $11.24 | 2025 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shailesh Zaveri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.